---
figid: PMC11575457__OTT-17-1041-g0001
figtitle: '[KRAS signaling pathway and targeted therapeutic agents'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11575457
filename: OTT-17-1041-g0001.jpg
figlink: /pmc/articles/PMC11575457/figure/F1/
number: F1
caption: '[KRAS signaling pathway and targeted therapeutic agents.]'
papertitle: The Potential Treatment Options and Combination Strategies of KRAS-Mutated
  Lung Cancer
reftext: Xinchao Zhao, et al. Onco Targets Ther. 2024;17(NA).
year: '2024'
doi: 10.2147/OTT.S484209
journal_title: OncoTargets and Therapy
journal_nlm_ta: Onco Targets Ther
publisher_name: Dove Press
keywords: targeted therapies | sotorasib | adagrasib | resistance
automl_pathway: 0.9416353
figid_alias: PMC11575457__F1
figtype: Figure
redirect_from: /figures/PMC11575457__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11575457__OTT-17-1041-g0001.html
  '@type': Dataset
  description: '[KRAS signaling pathway and targeted therapeutic agents.]'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOS1
  - EGFR
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - ERBB2
  - GRB2
  - IGF1R
  - GAB1
  - PIGU
  - GAB2
  - GAB3
  - ITK
  - SLC22A3
  - PTPN11
  - ARHGEF2
  - SLC2A4RG
  - KRAS
  - NRAS
  - LINC00673
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - Linsitinib
  - Sorafenib
  - Trametinib
  - MEK
---
